Stock Track | Pediatrix Medical Plunges 6.19% in Pre-Market After Q4 Earnings Miss
Stock Track
Feb 19
Pediatrix Medical Group's stock experienced a significant pre-market plunge of 6.19% on Thursday.
The sharp decline follows the company's release of its fourth-quarter financial results, which revealed a miss on key analyst estimates. Pediatrix reported adjusted earnings per share of $0.50, falling short of the consensus estimate of $0.54. Furthermore, the company's adjusted EBITDA of $65.845 million came in below the estimated $71.1 million.
While quarterly revenue of $493.771 million surpassed expectations, it represented a year-over-year decrease. The earnings disappointment appears to be the primary driver behind the negative investor sentiment in the pre-market session.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.